Tyra Biosciences prices $400 million equity offering to fund dabogratinib development and other programs
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Finance & Markets
HK retail sales could rise by 8.4pc in 2026: Deloitte
Accounting giant Deloitte on Monday raised its full-year forecast for the city's retail sales to a growth of 8.4 percent year on year to HK$412 billion in 2026.
India's inflation rises to 4.82% in August, marginally exceeding forecasts
India's inflation in August accelerated for the tenth month straight to 4.82% in August amid rising food and fuel prices.
Lemonade's Loss Ratio Improved to 60%, and Its Gross Profit Rose 76%. The Stock Is Still 49% Off Its High.
Is it a buy on the dip or a value trap?
